Evidence map›Paper›PMID 36879635›Full record

ArticleThe Pan African medical journal2022

[Clinical and epidemiological features of COVID-19-related deaths in Tunisia before the emergence of VOCs (March 2020-February 2021)].

Sonia Dhaouadi, Aicha Hechaichi, Hajer Letaief, Mouna Safer, Emna Mziou, Khouloud Talmoudi, Chiraz Borgi, Henda Chebbi, Naoufel Somrani, Mohamed Belahj Ali and 5 more

Abstract readEnglish Abstract
In one paragraph

Article in The Pan African medical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Sonia DhaouadiObservatoire National des Maladies Nouvelles et Emergentes, Tunis, Tunisie.
Aicha HechaichiObservatoire National des Maladies Nouvelles et Emergentes, Tunis, Tunisie.
Hajer LetaiefObservatoire National des Maladies Nouvelles et Emergentes, Tunis, Tunisie.
Mouna SaferObservatoire National des Maladies Nouvelles et Emergentes, Tunis, Tunisie.
Emna MziouObservatoire National des Maladies Nouvelles et Emergentes, Tunis, Tunisie.
Khouloud TalmoudiObservatoire National des Maladies Nouvelles et Emergentes, Tunis, Tunisie.
Chiraz BorgiMinistère de la Santé, Tunis, Tunisie.
Henda ChebbiMinistère de la Santé, Tunis, Tunisie.
Naoufel SomraniMinistère de la Santé, Tunis, Tunisie.
Mohamed Belahj AliDirection Régionale de la Santé, Tunis, Tunisie.
Souad YahyaouiDirection Régionale de la Santé, Tunis, Tunisie.
Amal MseddiDirection Régionale de la Santé, Tunis, Tunisie.
Mohamed Kouni ChahedFaculté de Médecine de Tunis, Université Tunis El Manar, Tunis, Tunisie.
Mustapha FerjaniFaculté de Médecine de Tunis, Université Tunis El Manar, Tunis, Tunisie.
Nissaf Bouafif-Ben AlayaObservatoire National des Maladies Nouvelles et Emergentes, Tunis, Tunisie.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: the purpose of this study was to describe the clinical and epidemiological features of COVID-19-related deaths in Tunisia notified at the ONMNE (National Observatory of New and emerging Diseases) between 2 Methods: we conducted a national prospective longitudinal descriptive study of data collected from the National Surveillance System of SARS-CoV-2 infection of the ONMNE, Ministry of Health. All COVID-19-related deaths that occurred in Tunisia between March 2020 and February 2021 were included in this study. Data were collected from hospitals, municipalities and regional health departments. Death notifications were collected from multiple data sources (triangulation): The Regional Directorate of Basic Health Care, the ShocRoom (Strategic Health Operations Center), public and private health facilities, the Crisis Unit of the Presidency of the Government, the Directorate for Hygiene and Environmental Protection, the Ministry of Local Affairs and the Environment, as part of the follow-up of confirmed cases by the ONMNE team, positive RT-PCR / TDR post mortem results. Results: during this study, 8051 deaths were recorded, corresponding to a proportional mortality of 10.4%. The median age was 73 years, with an interquartile range of 17 years. Sex-ratio (M/F) was 1.8. The crude death rate was 69.1/100 000 inhabitants and fatality rate was 3.5%. The analysis of the epidemic curve showed 2 peaks of deaths on 29 Conclusion: prevention strategy based on public health measures must be reinforced by the rapid deployment of anti-COVID-19 vaccination, especially for people at risk of death.

Indexed as

COVID-19AdolescentHumansProspective StudiesPublic HealthSARS-CoV-2TunisiaCOVID-19epidemicepidemiological surveillancemortalitystandardizationTunisia

Identifiers

PMID36879635
PMCPMC9984832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.